September 2012 
Volume 42  Number 9
Pages 22 - 22
  PDF Version Available!

Twenty-two patients taking olmesartan were evaluated at the Mayo Clinic (Rochester, Minn.) for unexplained chronic diarrhea, weight loss, and enteropathy. Olmesartan is an angiotensin II receptor antagonist commonly prescribed for hypertension. Most of the patients were taking 40 mg/day (dosage range, 10 to 40 mg/day).Celiac disease was ruled out for all 22 patients because none of them had responded to a gluten-free diet. As revealed by intestinal biopsies, 15 patients had villous atrophy and mucosal inflammation and 7 had subepithelial collagen deposits (collagenous sprue). Researchers also documented seven cases of collagenous or lymphocytic gastritis and five cases of microscopic colitis.All 22 patients responded well when olmesartan was discontinued, with a mean weight gain of 12.2 kg (26.9 lb). Intestinal recovery or improvement was confirmed in all 18 patients who later underwent follow-up biopsies.Researchers concluded that olmesartan may be associated with severe spruelike enteropathy

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!

1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.

Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events